Reza Shojaei: On The 2nd Day of IPAW 2025, Let’s Focus on Patients, The Real Reason Plasma Matters!
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
”On the second day of IPAW 2025, let’s focus on patients, the real reason plasma matters.
Plasma-derived medicines treat life-threatening conditions such as primary immune deficiencies, hemophilia, and hereditary angioedema.
For many, these therapies are not optional; they are the only available treatment, turning what used to be fatal diseases into manageable conditions.
Every donation ensures someone, somewhere, gets another chance at health, at family life, at simply living fully.
Behind each unit of plasma is a powerful chain: a donor’s generosity, a patient’s survival, and then a family’s hope.
Let’s use this week to amplify the voices of patients and remind the world that plasma saves lives every single day.
If you know someone whose life has been touched by plasma therapies, share their story on social media, because awareness grows stronger when it’s personal.”
Stay updated on emerging topics in transfusion medicine with Hemostasis Today.
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management